Skip to content
Screener

Veradermics MANE Total debt

Total debt at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$49.04B-3.4%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$157.93M+149%
Organon logo
OrganonOGN
$8.57B-4.3%
PVL
Palvella TherapeuticsPVLA
$584K
TTR
Turn Therapeutics Inc.TTRX
$6.01M
PTH
Pelthos Therapeutics Inc.PTHS
$29.65M

Other financials

Income statement

See full
Operating income-$29.9M-131%
Net income-$27.2M-120%
EPS (diluted)-$1.32+93.3%

Balance sheet

See full
Cash & equivalents$168.4M+419%
Total equity$390.6M+744%
Total assets$397.4M

Cash flow

See full
Operating cash flow-$21.2M-59.0%
CapEx--100%
Free cash flow-$21.2M-58.7%

Valuation

See full
Market cap$4.48B+269%

Returns & leverage

See full
Return on equity-28.7%
Current ratio59.1×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $4K.

The source filing: Veradermics’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 5:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001827635-26-000019

FAQ

What is Veradermics's total debt?
Veradermics (MANE) reported total debt of $4K in Q4 2025.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.

Ask your AI about Veradermics's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude